On 9 February 2026, Sinohealth Holdings Limited (2361) announced that its current public float stands at 16.45%, below the minimum 25% required under Rule 13.32B(1) of the Listing Rules. The shortfall is primarily attributed to 39,958,477 shares, representing about 8.84% of the company’s issued share capital, which are share awards not yet granted and therefore excluded from the public float.

According to the announcement, the company intends to grant the outstanding share awards over the next three years, targeting an annual grant to non-core connected persons of at least 2% of total share capital each year in 2026, 2027, and 2028. This plan aligns with Sinohealth Holdings Limited’s strategic and performance metrics, using a mix of company-level and individual-level criteria.

The company also disclosed two additional measures aimed at further bolstering its public float: pursuing equity financing to expand share capital and exploring arrangements for major shareholders to place part of their holdings with independent third parties. Sinohealth Holdings Limited expects these steps to increase the overall public float by at least eight percentage points by the end of June 2027.

The company will provide monthly updates on its progress toward meeting the prescribed 25% public float threshold and will continue to fulfill all relevant obligations under the Listing Rules until compliance is restored.